Log In
Print
BCIQ
Print
Print this Print this
 

Zostavax

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionLive attenuated zoster virus vaccine
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationVaricella zoster virus (VZV)
Indication DetailsPrevent shingles (herpes zoster) and reduce shingles associated pain; Prevent shingles (herpes zoster) in adults 60 years or older; Vaccinate against shingles (herpes zoster); Vaccinate against shingles (herpes zoster) in adults ages 50-59
Regulatory Designation

Partner

Sanofi


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today